WESTBOROUGH, Mass., July 17 /PRNewswire/ -- IBC announced today the preliminary list of companies selected for presentations at the Early Stage Company Showcase. The showcase will be held on August 10, 2006 during the R&D Strategies & Business Alliances conference, part of IBC’s 11th Annual Drug Discovery Technology(R) and Development World Congress at the Seaport Hotel/World Trade Center in Boston, MA to be held August 7-10, 2006.
The showcase gives emerging and early stage companies the opportunity to present their novel technology, innovative scientific concept or creative business model in front of a targeted audience and potential investors and partners. Each presenter will be given 10 minutes to introduce their company, describe their technology or strategy and how it adds value to drug discovery and development, discuss their partnering objectives and business model as well as their current and future plans for investor funding and revenue goals.
The selection committee has chosen the preliminary list of 12 companies for presentations. In addition, the committee has reserved 4 slots for late-breaking abstracts and is on the look-out for new companies launching unique products and technologies
The 12 selected companies listed by category are: Category 1: Drug Product 1) Claus Kremoser, Chief Executive Officer, Phenex AG 2) Zahed Subhan, Chief Executive Officer, Marillion Pharmaceuticals 3) Jane Hollingsworth, Chief Executive Officer, NuPathe, Inc. Category 2: Therapeutic and Diagnostics Platforms 4) Philippe Goix, President & CEO, Singulex Inc. 5) Bart Van de Vyver, Chief Executive Officer, SpinX Technologies 6) Richard Begley, President & CEO, Ensemble Discovery 7) Gordon A Jamieson, Jr., President, Translational Therapeutics, Inc. Category 3: Technology Platforms 8) Victor Bronshtein, President & Chief Scientific Officer, Universal Stabilization Technologies 9) Israel Biran, Chief Operating Officer, Molecular Cytomics 10) Mattias Karlsson, Chief Operating Officer, Cellectricon 11) Raj Singh, President & Chief Scientific Officer, Vivo Biosciences 12) Edwin Addison, Chief Executive Officer, TeraDisc, LLC
Complete details on the showcase and the Drug Discovery Technology(R) & Development World Congress can be found at http://www.drugdisc.com/us. To receive a press pass go to http://www.drugdisc.com/press
About Drug Discovery Technology(R) & Development World Congress Drug Discovery Technology(R) & Development World Congress (DDT), now in its 11th year, is the industry’s premier, international conference and exhibition to provide education on the most vital topics in drug discovery and development to help accelerate products to market. The event provides a meeting place for attendees from around the world to network, find business and scientific partners and to discuss scientific advances, R&D strategies, business alliances and informatics solutions in drug discovery and development.
About IBC Life Sciences
IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. To develop its programs, IBC actively researches the advancements, technologies and trends impacting and driving the race for new drugs and therapies. No other organization can make claim to the breadth and quality that IBC Life Sciences delivers in each event giving the company recognition around the globe for quality, service and value. For more information, visit: http://www.IBCLifeSciences.com.
Contact: Dawn Eagan IBC Life Sciences 508-614-1679 deagan@ibcusa.com
IBC Life Sciences
CONTACT: Dawn Eagan of IBC Life Sciences, +1-508-614-1679,deagan@ibcusa.com
Web site: http://www.lifesciencesinfo.com/
